English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Pfizer CEO says $7 billion available for acquisitions as company maintains dividend
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Study links high childhood BMI to increased likelihood of adult childlessness in Denmark
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

UC Davis Health study links better sleep to academic and social success in adolescents
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Analysts discuss potential impact of rumored Bristol Myers Squibb and AstraZeneca merger
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Study finds dementia risk disparities after age 90 among diverse groups
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Study finds exercise slows cognitive decline in Hispanic adults, blood sugar key for others
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

BioNTech lowers sales forecast amid declining COVID-19 vaccine demand
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Study finds improved sleep boosts academic performance in university students

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'